(Q44726080)

5 December 2017

title

Potent bivalent inhibition of human tryptase-beta by a synthetic inhibitor (English)

1 reference

5 December 2017

Trevor Selwood

1

1 reference

5 December 2017

Kyle C Elrod

series ordinal

2

1 reference

5 December 2017

Norman M Schechter

series ordinal

3

1 reference

5 December 2017

publication date

1 December 2003

1 reference

5 December 2017

1 reference

5 December 2017

volume

384

1 reference

5 December 2017

issue

12

1 reference

5 December 2017

page(s)

1605-1611

1 reference

Potent selective nonpeptidic inhibitors of human lung tryptase.

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.178

Monocharged inhibitors of mast cell tryptase derived from potent and selective dibasic inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.178

High-throughput screening of enzyme inhibitors: automatic determination of tight-binding inhibition constants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.178

Human beta-tryptase is a ring-like tetramer with active sites facing a central pore

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.178

Thermodynamic analysis of ion effects on the binding and conformational equilibria of proteins and nucleic acids: the roles of ion association or release, screening, and ion effects on water activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.178

Bivalent inhibition of human beta-tryptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.178

Bivalent inhibition of beta-tryptase: distance scan of neighboring subunits by dibasic inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.178

Structural changes associated with the spontaneous inactivation of the serine proteinase human tryptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.178

Spontaneous inactivation of human tryptase involves conformational changes consistent with conversion of the active site to a zymogen-like structure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.178

Diverse stability and catalytic properties of human tryptase alpha and beta isoforms are mediated by residue differences at the S1 pocket

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.178

Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.178

Recombinant expression of human mast cell proteases chymase and tryptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.178

21 January 2018

Identifiers

DOI

10.1515/BC.2003.178

1 reference

5 December 2017

1 reference